Cargando…
Screening Of Pulmonary Hypertension in Methamphetamine Abusers (SOPHMA): rationale and design of a multicentre, cross-sectional study
INTRODUCTION: Methamphetamine misuse is classified as a ‘likely’ risk factor for pulmonary arterial hypertension (PAH). Nevertheless, the actual prevalence of and a screening strategy for PAH in methamphetamine users have not been established. We plan to study the prevalence of PAH and identify its...
Autores principales: | Cheng, Yangyang, Tung, Chi-Kwong, Chung, Albert Kar Kin, Liu, Wan-Wan, Huang, Duo, Chan, Pak Hei, Lam, Ming, Chan, Wai-Chi, Siu, Chung-Wah, Hai, Jo Jo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688696/ https://www.ncbi.nlm.nih.gov/pubmed/31375608 http://dx.doi.org/10.1136/bmjopen-2018-027193 |
Ejemplares similares
-
Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease
por: Chan, Pak Hei, et al.
Publicado: (2015) -
Burden of upper gastrointestinal symptoms in patients prescribed dabigatran for stroke prevention
por: Chan, Pak-Hei, et al.
Publicado: (2016) -
Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure Registry
por: Hai, Jo-Jo, et al.
Publicado: (2016) -
Quinidine for Brugada syndrome: Panacea or poison?
por: Hai, Jo-Jo, et al.
Publicado: (2016) -
Continuation of Dabigatran Therapy in “Real-World” Practice in Hong Kong
por: Ho, Mei Han, et al.
Publicado: (2014)